nach oben

European Journal of Trauma and Emergency Surgery

Erschienen in:

01.02.2012 | Review Article

Evidence for improved outcome following use of hemostatic fibrin sealants in HPB surgery?

verfasst von: R. Andersson

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The development of fibrin sealants has been progressing; they are now often applied as fibrinogen-coated collagen patches.

Materials and methods

The concept has been increasingly applied in hepato-pancreato-biliary surgery, for example, following liver resection, and to some extent also in pancreatic surgery, both in order to reinforce the pancreatic anastomosis at pancreaticoduodenectomy and to seal the pancreatic stump following distal pancreatectomy.

Conclusion

High quality evidence in the form of major prospective, randomized clinical studies is still lacking on in the field of HPB. There is also an the absence of proper cost-utility analyses.

Bergel S. Uber Wirkungen des Fibrins. Dtsch Med Wochenschr. 1909;35:633.CrossRef

Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost. 1995;74:482–5.PubMed

Busuttil RW. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg. 2003;197:1021–8.PubMedCrossRef

Schiele U, Kuntz G, Riegler A. Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue. Clin Mater. 1992;9:169–77.PubMedCrossRef

Erdogan D, van Gulik TM. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. J Biomed Mater Res Part B Appl Biomater. 2008;85B:272–8.CrossRef

Frilling A, Stavrou G, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, Thörne A, Gloor B, Beckebaum S, Ghaffar MFA, Broelsch CE. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg. 2005;390:114–20.PubMedCrossRef

Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007;24:288–93.PubMedCrossRef

Apestegui C, Breitenstein S, Dutkowski P, Clavien P-A. Control of severe portal bleeding by carrier-bound fibrin sealant. Surg Today. 2009;39:363–5.PubMedCrossRef

Dregelid E, Ramnefjell MP, Erichsen C, Christensen BJ, Rawal R. Effective hemostasis in severe mesenteric vein laceration with TachoSil^®, using a low- or non-thrombogenic patch to prevent TachoSil-induced thrombosis. Eur J Trauma Emerg Surg. 2008;34:177–80.CrossRef

10.

Lacanna F, Brunati A, Reding R. A new biological mesh for cut surface hemostasis in liver transplantation using technical variants. Pediatr Transplant. 2008;12:520–1.PubMedCrossRef

11.

Erdogan D, de Graaf W, van Gulik TM. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res. 2008;41:298–302.PubMedCrossRef

12.

Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO II, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004;139:1148–54.PubMedCrossRef

13.

Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of a randomized study in 300 patients. Ann Surg. 2007;245:536–42.PubMedCrossRef

14.

Couto J, Kroczek B, Requena R, Lerner R. Autologous fibrin glue as a sealant of the common bile duct. Surgery. 1987;101:354–6.PubMed

15.

Wise PE, Wudel LJ, Belous AE, Allos TM, Kuhn SJ, Feurer ID, Washington MK, Pinson CW, Chapman WC. Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg. 2002;68:553–62.PubMed

16.

Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, The International Study Group of Pancreatic Fistula, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef

17.

Balcom JHT, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391–8.PubMedCrossRef

18.

Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207:490–8.PubMedCrossRef

19.

Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg. 2009;13:163–73.PubMedCrossRef

20.

Goh BKP, Tan YM, Chung YFA, Cheow PC, Chan WH, Chow PKH, Soo KC, Wong WK. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula. A 21-year experience at a single institution. Arch Surg. 2008;143:956–65.PubMedCrossRef

21.

Rodriguez JR, Germez SS, Pandharipande PV, Gazelle GS, Thayer SP, Warshaw AL, Fernandez-del-Castillo C. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg. 2006;141:361–6.PubMedCrossRef

22.

Shrikhande SV, D’Souza MA. Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management. World J Gastroenterol. 2008;14:5789–96.PubMedCrossRef

23.

D’Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: is it useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol. 1994;26:283–6.PubMed

24.

Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, Yeo CJ. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–74.PubMedCrossRef

25.

Fisher WE, Chai C, Hodges SE, Wu MF, Hilsenbeck SG, Brunicardi FC. Effect of BioGlue^® on the incidence of pancreatic fistula following pancreas resection. J Gastrointest Surg. 2008;12:882–90.PubMedCrossRef

26.

Schulick RD. Complications after pancreaticoduodenectomy: intraabdominal abscess. J Hepatobiliary Pancreat Surg. 2008;15:252–6.PubMedCrossRef

27.

Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmières F, Sastre B, Fagniez PL, The French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection. Prospective randomized trial. Ann Surg. 2003;237:57–65.PubMedCrossRef

28.

Fingerhut A, Veyrie N, Ata T, Alexakis N, Leandros E. Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg. 2009;26:7–14.PubMedCrossRef

Titel: Evidence for improved outcome following use of hemostatic fibrin sealants in HPB surgery?
verfasst von: R. Andersson
Publikationsdatum: 01.02.2012
Verlag: Springer-Verlag
Erschienen in: European Journal of Trauma and Emergency Surgery / Ausgabe 1/2012
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-010-0031-z

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Evidence for improved outcome following use of hemostatic fibrin sealants in HPB surgery?

Abstract

Introduction

Materials and methods

Conclusion

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Update Orthopädie und Unfallchirurgie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Materials and methods

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Hip fracture surgery and performance indicators: an analysis of 941 patients operated in a large teaching hospital

Pediatric fractures: temporal trends and cost implications of treatment under general anesthesia

Biomechanical comparison of two locking plate systems for the distal tibia

Ultrasonographic evaluation of costal cartilage fractures unnoticed by the conventional radiographic study and multidetector computed tomography

Optic nerve sheath measurement and raised intracranial pressure in paediatric traumatic brain injury

Regionalisation of trauma care in Germany: the “TraumaNetwork DGU®-Project”

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Update Orthopädie und Unfallchirurgie